3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Neuroendocrine Tumors
8
Carcinoid Tumor
3
Acromegaly
3
Pituitary Neoplasms
2
Neoplasm Metastasis
2
Gastro-enteropancreatic neuroendocrine tumor
2
Carcinoma, Hepatocellular
2
Pheochromocytoma
1
Paraganglioma
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Growth Hormone-Secreting Pituitary Adenoma
1
Gigantism
1
Gastrointestinal Neoplasms
1
Carcinoma, Merkel Cell
1
Interventions
lanreotide
1
Temozolomide
1
Surveys and Questionnaires
1
Solutions
1
Radiosurgery
1
Microarray Analysis
1
Injections
1
Early Intervention, Educational
1
Diet, Mediterranean
1
Diet, Ketogenic
1
DNA Methylation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Growth Hormone-Secreting Pituitary Adenoma
×
lanreotide
×
Clear all
NCT03439709
2018-03-01
MERGE
Samsung Medical Center
Phase 3
Unknown
90 enrolled